DESIGN THERAPEUTICS INC (DSGN) Stock Analyst Earnings Estimates
NASDAQ:DSGN - Nasdaq - US25056L1035 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 830K | 230K -72.29% | -100.00% | 5.1M | 55.083M 980.06% | 222.55M 304.03% | 447.94M 101.28% | 722.98M 61.40% | |||||||
| EBITDA YoY % growth | N/A | -8.32M | -39.135M -329.09% | -69.3M -88.18% | -79.501M -15.31% | -92.31M 20.73% | -107.424M -74.95% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -1.91M | -8.33M -336.13% | -38.106M -330.13% | -69.193M -88.64% | -84.211M -15.40% | -63.769M 20.51% | -84.614M -36.47% | -91.835M -8.53% | -130.41M -42.00% | -184.434M -41.43% | -219.07M -18.78% | -122.819M 43.94% | 46.711M 138.03% | 271M 480.16% | |
| Operating Margin | -230.12% | -3,621.74% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -3,616.36% | -397.71% | -55.19% | 10.43% | 37.48% | |
| EPS YoY % growth | N/A | N/A | -0.82 | -1.19 -32.56% | -1.32 -5.26% | -0.92 26.67% | -1.36 -54.16% | -1.26 7.27% | -1.28 -1.76% | -1.66 -29.88% | -1.34 19.33% | -0.54 59.70% | 0.52 196.23% | 1.74 234.31% |
All data in USD
| Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.34 -60.29% | -0.35 -50.78% | -0.35 -45.92% | -0.34 -8.58% | -0.36 -6.06% | -0.37 -5.88% | -0.38 -7.77% |
| Revenue Q2Q % growth | N/A | N/A | N/A | ||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -20.819M -38.79% | -21.312M -31.18% | -21.663M -29.76% | -19.914M 2.47% | -21.84M -4.90% | -22.362M -4.93% | -23.211M -7.15% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | -0.31 -55.00% | -0.29 | -0.02 | -8.54% |
| Q4 2024 Q2Q % growth | -0.24 -14.29% | -0.27 | 0.03 | 11.77% |
| Q3 2024 Q2Q % growth | -0.23 17.86% | -0.25 | 0.02 | 7.33% |
| Q2 2024 Q2Q % growth | -0.21 41.67% | -0.24 | 0.03 | 11.76% |
| Q1 2024 Q2Q % growth | -0.20 42.86% | -0.27 | 0.07 | 25.54% |
| Q4 2023 Q2Q % growth | -0.21 32.26% | -0.32 | 0.11 | 33.53% |
| Q3 2023 Q2Q % growth | -0.28 12.50% | -0.42 | 0.14 | 32.80% |
| Q2 2023 Q2Q % growth | -0.36 -33.33% | -0.41 | 0.05 | 11.21% |
| Q1 2023 Q2Q % growth | -0.35 -45.83% | -0.37 | 0.02 | 4.49% |
| Q4 2022 Q2Q % growth | -0.31 -55.00% | -0.35 | 0.04 | 11.65% |
| Q3 2022 Q2Q % growth | -0.32 -52.38% | -0.29 | -0.03 | -8.93% |
| Q2 2022 Q2Q % growth | -0.27 -92.86% | -0.26 | -0.02 | -5.88% |
| Q1 2022 Q2Q % growth | -0.24 22.58% | -0.22 | -0.02 | -6.95% |
| Q4 2021 Q2Q % growth | -0.20 | -0.23 | 0.03 | 13.50% |
| Q3 2021 Q2Q % growth | -0.21 | -0.14 | -0.07 | -47.06% |
| Q2 2021 Q2Q % growth | -0.14 | -0.19 | 0.05 | 25.13% |
| Q1 2021 Q2Q % growth | -0.31 | -0.07 | -0.24 | -314.46% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2021 Q2Q % growth | -100.00% | % | ||
| Q1 2021 Q2Q % growth | -100.00% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -11.23% | 0% | -9.92% |
| Revenue | N/A | N/A | N/A | N/A |